Almost all cases of APL exhibit a PML::RARA genetic rearrangement resulting from the chromosomal translocation t(15;17)(q24;q21) and are highly responsive to differentiation therapy with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO). Here, PML is linked to acute promyelocytic leukemia.